CR

CRISM Therapeutics Corporation

Overview

Corporate Details

ISIN(s):
VGG042401262
LEI:
213800XFW6MKVCHHPW88
Country:
Virgin Islands (British)
Address:
C/O MAPLES FINANCE BVI LIMITED, VG1110 ROAD TOWN
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

No description available.

Stop Scraping. Start Analyzing.

You're viewing a fraction of the data available for CRISM Therapeutics Corporation. Get complete, real-time, and AI-ready data via the API the pros use.

Get Instant API & Bulk Data Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-26 17:03
Post-Annual General Meeting Information
Result of AGM
English 25.8 KB
2025-08-26 08:00
Post-Annual General Meeting Information
AGM Statement
English 15.6 KB
2025-08-12 08:00
Regulatory News Service
GMP Manufacture of ChemoSeed
English 16.9 KB
2025-07-10 16:04
Major Shareholding Notification
Holding(s) in Company
English 23.3 KB
2025-07-03 08:00
Share Issue/Capital Change
Result of Retail Offer and Additional Placing
English 16.8 KB
2025-07-01 17:41
Capital/Financing Update
Update presentation on the IMC platform
English 14.9 KB
2025-06-30 08:01
Share Issue/Capital Change
Retail Offer
English 39.0 KB
2025-06-30 08:00
Share Issue/Capital Change
Placing
English 58.0 KB
2025-03-31 08:00
Legal Proceedings Report
Clinical Trial Update
English 17.3 KB
2025-03-27 08:00
Regulatory News Service
Innovate UK Grant Award
English 20.3 KB

Automate Your Workflow. Get a real-time feed of all CRISM Therapeutics Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CRISM Therapeutics Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Fluicell AB Logo
Developing bioprinted tissues for regenerative medicine and advanced drug screening.
Sweden FLUI
FluoGuide A/S Logo
Develops fluorescent drugs to guide surgeons for more precise cancer removal and patient outcomes.
Denmark FLUO
FUSION ANTIBODIES PLC Logo
A CRO providing end-to-end antibody engineering services for therapeutic & diagnostic development.
United Kingdom FAB
FUTURA MEDICAL PLC Logo
Develops topical sexual health gels, including a fast-acting, over-the-counter ED treatment.
United Kingdom FUM
Gabather AB Logo
Clinical-stage pharma developing GABAA therapeutics for neuropsychiatric disorders.
Sweden GABA
GEIGER COUNTER LIMITED Logo Jersey GCL
Geneuro Logo
Develops HERV-targeting treatments for neurodegenerative and autoimmune diseases.
Switzerland GEM
GENFIT Logo
Biopharma firm developing therapies & diagnostics for rare and severe liver diseases.
France GNFT
GENFLOW BIOSCIENCES PLC Logo
Developing gene therapies to target the aging process in humans and dogs.
United Kingdom GENF
GENINCODE PLC Logo
AI-powered genetic tests for physicians, predicting and preventing cardiovascular disease.
United Kingdom GENI